Dispersal of group a streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Connolly, Kristie L ^a   Roberts, Amity L ^a   Holder, Robert C ^a   Reid, Sean D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; PROTEIN SPEB; UNCLASSIFIED DRUG; STREPTOPAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; BIOFILM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; SKIN INFECTION; ANIMAL; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; VIRULENCE;

ANIMALIA; MURINAE; MUS; POSIBACTERIA; STREPTOCOCCUS SP. 'GROUP A';

ANIMALS; BIOFILMS; CYSTEINE ENDOPEPTIDASES; FEMALE; MICE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VIRULENCE;

EID: 79955560044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018984     Document Type: Article

References (71)

1. Gabillot-Carre M, Roujeau JC, (2007) Acute bacterial skin infections and cellulitis. Curr Opin Infect Dis 20: 118-123.
2. Martin JM, Green M, (2006) Group A streptococcus. Semin Pediatr Infect Dis 17: 140-148.
3. Rogers RL, Perkins J, (2006) Skin and soft tissue infections. Prim Care 33: 697-710.
4. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, et al. (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41: 1373-1406.
5. Cunningham MW, (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
6. Heslop A, Ovesen T, (2006) Severe acute middle ear infections: microbiology and treatment. Int J Pediatr Otorhinolaryngol 70: 1811-1816.
7. Musser JM, DeLeo FR, (2005) Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am J Pathol 167: 1461-1472.
8. Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, et al. (2005) Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 41: 35-41.
9. Stahelin-Massik J, Podvinec M, Jakscha J, Rust ON, Greisser J, et al. (2008) Mastoiditis in children: a prospective, observational study comparing clinical presentation, microbiology, computed tomography, surgical findings and histology. Eur J Pediatr 167: 541-548.
10. Lukomski S, Burns EH Jr, Wyde PR, Podbielski A, Rurangirwa J, et al. (1998) Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 66: 771-776.
11. Nagamune H, Ohkura K, Ohkuni H, (2005) Molecular basis of group A streptococcal pyrogenic exotoxin B. J Infect Chemother 11: 1-8.
12. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, et al. (2005) Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 192: 771-782.
13. Bisno AL, (2001) Acute pharyngitis. N Engl J Med 344: 205-211.
14. Akiyama H, Morizane S, Yamasaki O, Oono T, Iwatsuki K, (2003) Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J Dermatol Sci 32: 193-199.
15. Cho KH, Caparon MG, (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 57: 1545-1556.
16. Doern CD, Roberts AL, Hong W, Nelson J, Lukomski S, et al. (2009) Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiology 155: 46-52.
17. Tamura F, Nakagawa R, Akuta T, Okamoto S, Hamada S, et al. (2004) Proapoptotic Effect of Proteolytic Activation of Matrix Metalloproteinases by Streptococcus pyogenes Thiol Proteinase (Streptococcus Pyrogenic Exotoxin B). Infect Immun 72: 4836-4847.
18. Chiang-Ni C, Wu JJ, (2008) Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes. J Formos Med Assoc 107: 677-685.
19. Kapur V, Majesky MW, Li LL, Black RA, Musser JM, (1993) Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A 90: 7676-7680.
20. Lukomski S, Montgomery CA, Rurangirwa J, Geske RS, Barrish JP, et al. (1999) Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 67: 1779-1788.
21. Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, et al. (2002) EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis. Infect Immun 70: 6646-6651.
22. Terao Y, Mori Y, Yamaguchi M, Shimizu Y, Ooe K, et al. (2008) Group A Streptococcal Cysteine Protease Degrades C3 (C3b) and Contributes to Evasion of Innate Immunity. J Biol Chem 283: 6253-6260.
23. Chiang-Ni C, Wang CH, Tsai PJ, Chuang WJ, Lin YS, et al. (2006) Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A streptococcus. Med Microbiol Immunol 195: 55-63.
24. Goldmann O, Sastalla I, Wos-Oxley M, Rohde M, Medina E, (2009) Streptococcus pyogenes induces oncosis in macrophages through the activation of an inflammatory programmed cell death pathway. Cell Microbiol 11: 138-155.
25. Raeder R, Woischnik M, Podbielski A, Boyle MD, (1998) A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 149: 539-548.
26. Berge A, Bjorck L, (1995) Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270: 9862-9867.
27. Nyberg P, Rasmussen M, Von Pawel-Rammingen U, Bjorck L, (2004) SpeB modulates fibronectin-dependent internalization of Streptococcus pyogenes by efficient proteolysis of cell-wall-anchored protein F1. Microbiology 150: 1559-1569.
28. Doern CD, Holder RC, Reid SD, (2008) Point mutations within the streptococcal regulator of virulence (Srv) alter protein-DNA interactions and Srv function. Microbiology 154: 1998-2007.
29. Reid SD, Chaussee MS, Doern CD, Chaussee MA, Montgomery AG, et al. (2006) Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB. FEMS Immunol Med Microbiol 48: 283-292.
30. Chaussee MS, Liu J, Stevens DL, Ferretti JJ, (1996) Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 173: 901-908.
31. Chaussee MS, Phillips ER, Ferretti JJ, (1997) Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion. Infect Immun 65: 1956-1959.
32. Donlan RM, Costerton JW, (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
33. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW, (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1: 667-683.
34. Gilbert P, Das J, Foley I, (1997) Biofilm susceptibility to antimicrobials. Adv Dent Res 11: 160-167.
35. Dale JB, (1999) Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 17: 193-200.
36. Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, et al. (2006) Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 44: 2721-2727.
37. Conley J, Olson ME, Cook LS, Ceri H, Phan V, et al. (2003) Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol 41: 4043-4048.
38. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, et al. (2006) Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol 72: 2864-2875.
39. Luo F, Lizano S, Banik S, Zhang H, Bessen DE, (2008) Role of Mga in group A streptococcal infection at the skin epithelium. Microb Pathog 45: 217-224.
40. Manetti AG, Zingaretti C, Falugi F, Capo S, Bombaci M, et al. (2007) Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol 64: 968-983.
41. Roberts AL, Holder RC, Reid SD, (2010) Allelic replacement of the streptococcal cysteine protease SpeB in a Deltasrv mutant background restores biofilm formation. BMC Res Notes 3: 281.
42. Roberts AL, Connolly KL, Doern CD, Holder RC, Reid SD, (2010) Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect Immun.
43. Govrin E, Levine A, (1999) Purification of active cysteine proteases by affinity chromatography with attached E-64 inhibitor. Protein Expr Purif 15: 247-250.
44. Matsumoto K, Mizoue K, Kitamura K, Tse WC, Huber CP, et al. (1999) Structural basis of inhibition of cysteine proteases by E-64 and its derivatives. Biopolymers 51: 99-107.
45. Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, et al. (2006) Trigger for group A streptococcal M1T1 invasive disease. Faseb J 20: 1745-1747.
46. Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, et al. (1997) Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 99: 2574-2580.
47. Saouda M, Wu W, Conran P, Boyle MD, (2001) Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis 184: 723-731.
48. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM, (2006) Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2: e5.
49. Svensson MD, Scaramuzzino DA, Sjobring U, Olsen A, Frank C, et al. (2000) Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 38: 242-253.
50. Chaussee MS, Watson RO, Smoot JC, Musser JM, (2001) Identification of Rgg-regulated exoproteins of Streptococcus pyogenes. Infect Immun 69: 822-831.
51. Federle MJ, McIver KS, Scott JR, (1999) A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 181: 3649-3657.
52. Levin JC, Wessels MR, (1998) Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 30: 209-219.
53. Neely MN, Lyon WR, Runft DL, Caparon M, (2003) Role of RopB in growth phase expression of the SpeB cysteine protease of Streptococcus pyogenes. J Bacteriol 185: 5166-5174.
54. Kansal RG, Datta V, Aziz RK, Abdeltawab NF, Rowe S, et al. (2010) Dissection of the molecular basis for hypervirulence of an in vivo-selected phenotype of the widely disseminated M1T1 strain of group A Streptococcus bacteria. J Infect Dis 201: 855-865.
55. Mitrophanov AY, Churchward G, Borodovsky M, (2007) Control of Streptococcus pyogenes virulence: modeling of the CovR/S signal transduction system. J Theor Biol 246: 113-128.
56. Aziz RK, Ismail SA, Park HW, Kotb M, (2004) Post-proteomic identification of a novel phage-encoded streptodornase, Sda1, in invasive M1T1 Streptococcus pyogenes. Mol Microbiol 54: 184-197.
57. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE, et al. (2004) Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 51: 123-134.
58. Dalton TL, Hobb RI, Scott JR, (2006) Analysis of the role of CovR and CovS in the dissemination of Streptococcus pyogenes in invasive skin disease. Microb Pathog 40: 221-227.
59. Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ, (2001) Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 183: 1043-1054.
60. Trevino J, Perez N, Ramirez-Pena E, Liu Z, Shelburne SA 3rd, et al. (2009) CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun 77: 3141-3149.
61. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, et al. (2007) DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 13: 981-985.
62. Dalton TL, Scott JR, (2004) CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J Bacteriol 186: 3928-3937.
63. Loughman JA, Caparon M, (2006) Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J Bacteriol 188: 399-408.
64. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, et al. (2006) DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 16: 396-400.
65. Kansal RG, Nizet V, Jeng A, Chuang WJ, Kotb M, (2003) Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J Infect Dis 187: 398-407.
66. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, et al. (1982) L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201: 189-198.
67. Kagawa TF, O'Toole PW, Cooney JC, (2005) SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes. Mol Microbiol 57: 650-666.
68. Mangold M, Siller M, Roppenser B, Vlaminckx BJ, Penfound TA, et al. (2004) Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol 53: 1515-1527.
69. Reid SD, Montgomery AG, Musser JM, (2004) Identification of srv, a PrfA-like regulator of group A streptococcus that influences virulence. Infect Immun 72: 1799-1803.
70. Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, et al. (2000) Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68: 535-542.
71. Reid SD, Montgomery AG, Voyich JM, DeLeo FR, Lei B, et al. (2003) Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins. Infect Immun 71: 7043-7052.